PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28832499-0	2017	A Molecular Modeling Study of the Hydroxyflutamide Resistance Mechanism Induced by Androgen Receptor Mutations.	hydroxyflutamide	34-50	androgen receptor	Homo sapiens	83-100	
28832499-1	2017	Hydroxyflutamide (HF), an active metabolite of the first generation antiandrogen flutamide, was used in clinic to treat prostate cancer targeting androgen receptor (AR).	hydroxyflutamide	0-16	androgen receptor	Homo sapiens	146-163	
28832499-1	2017	Hydroxyflutamide (HF), an active metabolite of the first generation antiandrogen flutamide, was used in clinic to treat prostate cancer targeting androgen receptor (AR).	hydroxyflutamide	0-16	androgen receptor	Homo sapiens	165-167	
28832499-1	2017	Hydroxyflutamide (HF), an active metabolite of the first generation antiandrogen flutamide, was used in clinic to treat prostate cancer targeting androgen receptor (AR).	hydroxyflutamide	18-20	androgen receptor	Homo sapiens	146-163	
28832499-1	2017	Hydroxyflutamide (HF), an active metabolite of the first generation antiandrogen flutamide, was used in clinic to treat prostate cancer targeting androgen receptor (AR).	hydroxyflutamide	18-20	androgen receptor	Homo sapiens	165-167